Cryopreserved cord blood access program for transplant patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial studies an organized way to obtain and distribute unlicensed (not FDA-approved for general use) stored cord blood units that have been frozen and kept. It may help people who need a cord blood transplant but don’t fit the “licensed cord blood only” options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need a blood-related condition that involves bone marrow or blood cell production, from genetics, illness, or strong prior treatment.
- You will be asked to sign a consent form (and a child’s assent if the patient is a minor) before joining.
- You may be a child or an adult of any age.
- You cannot be using only licensed cord blood units.
- You must be using an unlicensed cord blood unit through this program—not already through another research/IND access protocol.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This trial tests a cord blood transplant after a reduced-intensity chemotherapy and radiation regimen for patients with high-risk blood cancers like leukemia, lymphoma, or MDS. The goal is to see if this approach can help destroy cancer cells and restore healthy blood cells.
This Phase 2 study tests using donated cord blood to treat certain adult blood cancers that are at high risk of coming back. It may help strengthen the body’s ability to rebuild blood and fight the cancer after intensive treatment.
This trial tests a special type of cord blood transplant using lab-grown stem cells to help the new blood-forming cells “take” sooner. It’s for people with severe aplastic anemia or certain MDS cases who have not responded well to standard immune-suppressing treatments.
This trial tests a specialized donor stem cell transplant to treat high-risk problems in the blood and bone marrow, including some cancers and non-cancers. It may help by using donor immune cells designed to better control the disease after transplant.
This trial studies whether unlicensed (not FDA-approved) cord blood units made by a specific program are safe to use for unrelated transplants. It may help doctors confirm safe ways to use these units for people who need a transplant for blood-forming system disorders.
Hear when a new Myelodysplastic (MDS) / Myeloproliferative (MPN) Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.